Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.

Details for Australian Patent Application No. 2008219585 (hide)

International Classifications

Event Publications

17 September 2009 PCT application entered the National Phase

PCT publication WO2008/106213 Priority application(s): WO2008/106213

28 January 2010 Amendment Made

The nature of the amendment is: Remove the coapplicant Titan Pharmaceuticals, Inc.

23 September 2010 Alteration of Name

The name of the applicant has been altered to The Government of the United States of America as represented by the Department of Veterans Affairs; The Arizona Board of Regents on behalf of the University of Arizona

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.